NLRP3 and breast neoplasm: Ershaid et al. (2019) found that in both mouse and human CAFs, the expression of NLRP3, caspase-1 and IL-1β are significantly upregulated in breast tumour samples [151], strongly suggesting that the tumour environment can prime the inflammasome.